On April 26, 2023, Gary A. Lyons notified Eledon Pharmaceuticals, Inc. that he is retiring from the Board of Directors of the Company at the end of his term and will not be standing for election at the Company's 2023 annual meeting of stockholders.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.96 USD | +2.07% | +4.23% | +64.44% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+64.44% | 114M | |
+16.93% | 123B | |
+17.01% | 111B | |
-7.23% | 23.63B | |
+1.98% | 22.58B | |
-14.29% | 17.26B | |
-6.79% | 17.6B | |
-37.63% | 17.61B | |
+2.17% | 13.55B | |
+24.42% | 11.34B |
- Stock Market
- Equities
- ELDN Stock
- News Eledon Pharmaceuticals, Inc.
- Eledon Pharmaceuticals, Inc. Announces Gary A. Lyons Not to Stand for Re-Election as Director